Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000336897 | SCV000383009 | likely benign | Autosomal dominant nonsyndromic hearing loss 3A | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV000407574 | SCV000383010 | likely benign | Ichthyosis, hystrix-like, with hearing loss | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV000278504 | SCV000383011 | likely benign | Autosomal recessive nonsyndromic hearing loss 1A | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
ARUP Laboratories, |
RCV000757332 | SCV000885516 | uncertain significance | not specified | 2018-07-01 | criteria provided, single submitter | clinical testing | The c.355G>A; p.Glu119Lys variant (rs150529554) was previously identified in patients with sensorineural hearing loss, but its pathogenicity could not be ascertained and an accompanying pathogenic GJB2 variant could not be identified (Jaradat 2016, Putcha 2007, Wu 2002). It is reported as likely benign in ClinVar (Variation ID: 188488) and is observed in the general population at an overall frequency of 0.009% (25/275896 alleles) in the Genome Aggregation Database. The glutamate at residue 119 is moderately conserved, but computational algorithms (PolyPhen-2, SIFT) predict that this variant is tolerated. Due to limited information regarding this variant, its clinical significance cannot be determined with certainty. References: Jaradat S et al. Molecular analysis of the GJB2 gene in Iraqi patients with sensorineural non-syndromic hearing loss. J Med J. J Med J 2016;50 (3):145- 155. Putcha G et al. A multicenter study of the frequency and distribution of GJB2 and GJB6 mutations in a large North American cohort. Genet Med. 2007;9(7):413-26. Wu B et al. Effectiveness of sequencing connexin 26 (GJB2) in cases of familial or sporadic childhood deafness referred for molecular diagnostic testing. Genet Med. 2002;4(4):279-88. |
Athena Diagnostics Inc | RCV001288924 | SCV001476376 | uncertain significance | not provided | 2020-03-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001288924 | SCV001771217 | uncertain significance | not provided | 2023-01-24 | criteria provided, single submitter | clinical testing | Observed as heterozygous with no other GJB2 variants in patients with hearing loss in published literature (Wu et al., 2002; Azaiez et al., 2004; Santos et al., 2005); In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 15365987, 12172394, 27153395, 25388846, 25087612, 15656949, 17666888) |
Clinical Molecular Genetics Laboratory, |
RCV000678880 | SCV000805073 | uncertain significance | Hearing loss | 2017-04-18 | no assertion criteria provided | clinical testing | |
Molecular Genetics Laboratory, |
RCV001175238 | SCV001338804 | uncertain significance | Sensorineural hearing loss disorder | 2019-01-10 | no assertion criteria provided | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001288924 | SCV001809130 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001288924 | SCV001953120 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Diagnostic Laboratory, |
RCV001288924 | SCV001978704 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Natera, |
RCV000278504 | SCV002086050 | uncertain significance | Autosomal recessive nonsyndromic hearing loss 1A | 2020-09-11 | no assertion criteria provided | clinical testing |